FDA Inspection 674356 — Prostrakan Inc.
The FDA completed an inspection of Prostrakan Inc. on Aug 3, 2010 in Bedminster, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 3, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bedminster, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 6704 | 21 CFR 310.305(c) | Submission of report to incorrect office |
| 6833 | 21 CFR 314.80(c)(2)(ii)(A) | Incomplete periodic safety report |